EP 1667769 A2 20060614 - USE OF GALANTHAMINE AND THE DERIVATIVES THEREOF IN THE PRODUCTION OF MEDICAMENTS
Title (en)
USE OF GALANTHAMINE AND THE DERIVATIVES THEREOF IN THE PRODUCTION OF MEDICAMENTS
Title (de)
VERWENDUNG VON GALANTHAMIN UND SEINEN DERIVATEN ZUM HERSTELLEN VON ARZNEIMITTELN
Title (fr)
UTILISATION DE GALANTHAMINE ET DE SES DERIVES POUR PREPARER DES PRODUITS PHARMACEUTIQUES
Publication
Application
Priority
- AT 2004000251 W 20040712
- AT 15382003 A 20030929
Abstract (en)
[origin: WO2005030332A2] The invention relates to the use of galanthamine and the cholinergically active derivatives thereof in the production of medicaments for preventive treatment of postoperative delirium and/or subsyndronal postoperative delirium.Galanthamine, the galathamine derivative(4aS, 6R, 8aS)-6-hydroxy-3-methoxy-11-methyl-4a,5,9,10-tetrahydro-6H-benzofuro[3a, 3, 2-ef] [2]benzazepinium bromide and analogous salts, hydrates or solvates are advantageously suited for use according to the invention.
IPC 1-7
A61P 25/28; A61P 25/14; A61P 25/16; A61P 3/10; A61P 25/08; A61P 9/10; A61P 25/00; A61K 31/55; C07D 491/10
IPC 8 full level
A61K 31/55 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); C07D 491/10 (2006.01)
CPC (source: EP US)
A61K 31/55 (2013.01 - EP US); A61P 3/10 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP); C07D 491/10 (2013.01 - EP US)
Citation (search report)
See references of WO 2005030332A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005030332 A2 20050407; WO 2005030332 A3 20050602; CA 2506282 A1 20050407; CN 1859949 A 20061108; EP 1667769 A2 20060614; MX PA05005570 A 20051018; NO 20052177 D0 20050503; NO 20052177 L 20050624; US 2006111341 A1 20060525
DOCDB simple family (application)
AT 2004000251 W 20040712; CA 2506282 A 20040712; CN 200480028347 A 20040909; EP 04737381 A 20040712; MX PA05005570 A 20040712; NO 20052177 A 20050503; US 53756805 A 20050715